Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Nature Communications|April 20, 2026
Structure-informed deep generation enables de novo metabolite annotation in untargeted metabolomicsHongmiao Wang, Haosong Zhang, Zheng-Jiang ZhuNature Communications|August 30, 2025
Knowledge and data-driven two-layer networking for accurate metabolite annotation in untargeted metabolomicsHaosong Zhang, Xinhao Zeng, Yandong Yin, et al.Frontiers in Pharmacology|December 4, 2024
Efficacy and safety of lebrikizumab for the treatment of moderate-to-severe atopic dermatitis: a systematic review and meta-analysisJinger Lin, Min Luo, Qianwei Zhuo, et al.Medicine|April 12, 2024
The top 100 most cited articles in the treatment of basal cell carcinoma over the last decade: A bibliometric analysis and reviewJinger Lin, Min Luo, Qianwei Zhuo, et al.Intractable & Rare Diseases Research|September 4, 2025
Rare but not to be overlooked: Epidemiology and strategies for rare dermatological diseases in ChinaYue Han, Qianwei Zhuo, Nuo Chen, et al.Nature Communications|November 5, 2022
Metabolite annotation from knowns to unknowns through knowledge-guided multi-layer metabolic networkingZhiwei Zhou, Mingdu Luo, Haosong Zhang, et al.Analytical Chemistry|September 4, 2023
AllCCS2: Curation of Ion Mobility Collision Cross-Section Atlas for Small Molecules Using Comprehensive Molecular RepresentationsHaosong Zhang, Mingdu Luo, Hongmiao Wang, et al.Nature Communications|March 31, 2023
A mass spectrum-oriented computational method for ion mobility-resolved untargeted metabolomicsMingdu Luo, Yandong Yin, Zhiwei Zhou, et al.Cancer Immunology Research|February 27, 2026
Constitutive STAT3 signaling, in comparison to STAT5, enhances CAR T cell efficacy and lowers systemic toxicityHaosong Zhang, Yusuke Ito, Hitomi Kasuya, et al.Frontiers in Pharmacology|July 25, 2024
Safety of tildrakizumab: a disproportionality analysis based on the FDA adverse event reporting system (FAERS) database from 2018-2023Jinger Lin, Xiangqi Chen, Min Luo, et al.Pageof 3